These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38134949)

  • 1. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.
    Aerts R; Mehra V; Groll AH; Martino R; Lagrou K; Robin C; Perruccio K; Blijlevens N; Nucci M; Slavin M; Bretagne S; Cordonnier C;
    Lancet Infect Dis; 2024 May; 24(5):e291-e306. PubMed ID: 38134949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients.
    Schwenk HT; Khan A; Kohlman K; Bertaina A; Cho S; Montoya JG; Contopoulos-Ioannidis DG
    Transplant Cell Ther; 2021 Apr; 27(4):292-300. PubMed ID: 33840441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasmosis after hematopoietic stem cell transplantation.
    Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C
    Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective study of the implementation of the qualitative PCR technique in biological samples for monitoring toxoplasmosis in pediatric patients receiving hematopoietic stem cell transplantation].
    Nigro MG; Figueroa C; Ledesma BA
    Rev Argent Microbiol; 2014; 46(1):24-9. PubMed ID: 24721270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations.
    Gajurel K; Dhakal R; Montoya JG
    Curr Opin Infect Dis; 2015 Aug; 28(4):283-92. PubMed ID: 26098500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach.
    Aerts R; Mercier T; Beckers M; Schoemans H; Lagrou K; Maertens J
    Clin Microbiol Infect; 2022 Mar; 28(3):440-445. PubMed ID: 34634458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review.
    Kitahara M; Hiroshima Y; Norose K; Hikosaka K; Kazumoto H; Uematsu N; Shishido T; Kaiume H; Sato K; Ueki T; Sumi M; Watanabe M; Kobayashi H
    Transpl Infect Dis; 2021 Dec; 23(6):e13726. PubMed ID: 34542220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of reactivated toxoplasmosis in haematopoietic stem cell transplant recipients: a prospective cohort study in a setting withholding prophylaxis.
    Štajner T; Vujić D; Srbljanović J; Bauman N; Zečević Ž; Simić M; Djurković-Djaković O
    Clin Microbiol Infect; 2022 May; 28(5):733.e1-733.e5. PubMed ID: 34555535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxoplasmosis in immunocompromised patients].
    Machala L; Kodym P; Malý M; Geleneky M; Beran O; Jilich D
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):59-65. PubMed ID: 26099608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.
    Cavattoni I; Ayuk F; Zander AR; Zabelina T; Bacher A; Cayroglu E; Knospe V; Illies T; Aepfelbacher M; Richard G; Kröger N; Bacher U
    Leuk Lymphoma; 2010 Aug; 51(8):1530-5. PubMed ID: 20578813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
    Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
    Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient.
    Osthoff M; Chew E; Bajel A; Kelsey G; Panek-Hudson Y; Mason K; Szer J; Ritchie D; Slavin M
    Transpl Infect Dis; 2013 Feb; 15(1):E14-9. PubMed ID: 23279790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serologic status of Toxoplasma gondii infection in pre- and post-heart transplantation in a pediatric population: A preliminary study.
    Orang E; Sayyahfar S; Mahdavi M; Khanaliha K; Amiri M
    Transpl Infect Dis; 2020 Aug; 22(4):e13339. PubMed ID: 32445414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients.
    Bretagne S; Costa JM; Foulet F; Jabot-Lestang L; Baud-Camus F; Cordonnier C
    Transpl Infect Dis; 2000 Sep; 2(3):127-32. PubMed ID: 11429023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical strain of Toxoplasma gondii causing fatal reactivation after hematopoietic stem cell transplantion in a patient with an underlying immunological deficiency.
    Stajner T; Vasiljević Z; Vujić D; Marković M; Ristić G; Mićić D; Pasić S; Ivović V; Ajzenberg D; Djurković-Djaković O
    J Clin Microbiol; 2013 Aug; 51(8):2686-90. PubMed ID: 23761151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.
    Conrad A; Le Maréchal M; Dupont D; Ducastelle-Leprêtre S; Balsat M; Labussière-Wallet H; Barraco F; Nicolini FE; Thomas X; Gilis L; Chidiac C; Ferry T; Wallet F; Rabodonirina M; Salles G; Michallet M; Ader F;
    Clin Microbiol Infect; 2016 Jul; 22(7):636-41. PubMed ID: 27172809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
    Wei HX; Wei SS; Lindsay DS; Peng HJ
    PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of toxoplasmosis in transplant recipients: an update.
    Dard C; Marty P; Brenier-Pinchart MP; Garnaud C; Fricker-Hidalgo H; Pelloux H; Pomares C
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):447-460. PubMed ID: 29855213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients.
    Sumi M; Aosai F; Norose K; Takeda W; Kirihara T; Sato K; Fujikawa Y; Shimizu I; Ueki T; Hirosima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
    Int J Hematol; 2013 Aug; 98(2):214-22. PubMed ID: 23749548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation.
    Lim Z; Baker B; Zuckerman M; Wade JJ; Ceesay M; Ho AY; Devereux S; Mufti GJ; Pagliuca A
    J Infect; 2007 Feb; 54(2):e83-6. PubMed ID: 16806484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.